Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.97
+8.8%
$3.89
$2.37
$7.63
$505.08M1.31921,519 shs1.31 million shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.34
+4.7%
$1.30
$0.92
$2.32
$511.87M1.311.26 million shs1.74 million shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$14.27
-5.2%
$9.34
$3.09
$15.35
$185.30M0.34148,148 shs141,807 shs
Transcat, Inc. stock logo
TRNS
Transcat
$72.23
+2.4%
$78.56
$67.56
$133.40
$673.18M0.792,639 shs87,059 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
0.00%+16.76%-1.24%+16.76%-21.54%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+3.08%+3.08%+4.69%-27.57%
Prenetics Global Limited stock logo
PRE
Prenetics Global
0.00%+13.52%+76.39%+78.15%+188.87%
Transcat, Inc. stock logo
TRNS
Transcat
0.00%-1.99%-7.61%-16.35%-38.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.97
+8.8%
$3.89
$2.37
$7.63
$505.08M1.31921,519 shs1.31 million shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.34
+4.7%
$1.30
$0.92
$2.32
$511.87M1.311.26 million shs1.74 million shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$14.27
-5.2%
$9.34
$3.09
$15.35
$185.30M0.34148,148 shs141,807 shs
Transcat, Inc. stock logo
TRNS
Transcat
$72.23
+2.4%
$78.56
$67.56
$133.40
$673.18M0.792,639 shs87,059 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
0.00%+16.76%-1.24%+16.76%-21.54%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+3.08%+3.08%+4.69%-27.57%
Prenetics Global Limited stock logo
PRE
Prenetics Global
0.00%+13.52%+76.39%+78.15%+188.87%
Transcat, Inc. stock logo
TRNS
Transcat
0.00%-1.99%-7.61%-16.35%-38.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.00
Hold$5.6041.06% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.75
Reduce$1.5515.67% Upside
Prenetics Global Limited stock logo
PRE
Prenetics Global
2.00
Hold$9.00-36.93% Downside
Transcat, Inc. stock logo
TRNS
Transcat
2.50
Moderate Buy$112.2055.34% Upside

Current Analyst Ratings Breakdown

Latest PRE, TRNS, LAB, and CTKB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/27/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Prenetics Global Limited stock logo
PRE
Prenetics Global
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Transcat, Inc. stock logo
TRNS
Transcat
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/22/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$116.00
8/13/2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold
8/13/2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold$1.55
7/17/2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/10/2025
Transcat, Inc. stock logo
TRNS
Transcat
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$105.00
(Data available from 10/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$196.04M2.58$0.03 per share114.40$3.07 per share1.29
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$172.27M2.97N/AN/A$1.27 per share1.06
Prenetics Global Limited stock logo
PRE
Prenetics Global
$57.05M3.25N/AN/A$13.20 per share1.08
Transcat, Inc. stock logo
TRNS
Transcat
$278.42M2.42$4.27 per share16.93$30.82 per share2.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$6.02M-$0.05N/AN/A-3.27%-1.66%-1.30%11/4/2025 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$138.88M-$0.32N/AN/AN/A-69.08%-20.23%-15.32%10/29/2025 (Estimated)
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$46.30M-$3.99N/AN/AN/A-87.92%-31.05%-24.16%10/6/2025 (Estimated)
Transcat, Inc. stock logo
TRNS
Transcat
$14.52M$1.4350.5127.46N/A4.64%6.66%5.09%10/27/2025 (Estimated)

Latest PRE, TRNS, LAB, and CTKB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2025Q3 2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.02N/AN/AN/A$18.00 millionN/A
10/27/2025Q2 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.44N/AN/AN/A$79.51 millionN/A
10/6/2025N/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$0.71N/AN/AN/A$21.70 millionN/A
9/12/2025Q2 2025
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A-$0.82N/A-$0.94N/A$17.68 million
8/6/2025Q1 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.40$0.59+$0.19$0.35$72.28 million$76.42 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
$2.8019.62%N/AN/A N/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.22
4.55
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
5.16
4.92
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
2.16
2.06
Transcat, Inc. stock logo
TRNS
Transcat
0.11
2.92
2.36

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Prenetics Global Limited stock logo
PRE
Prenetics Global
25.01%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
23.16%
Prenetics Global Limited stock logo
PRE
Prenetics Global
7.80%
Transcat, Inc. stock logo
TRNS
Transcat
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500127.22 million114.08 millionOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620382.00 million293.53 millionOptionable
Prenetics Global Limited stock logo
PRE
Prenetics Global
112.99 millionN/ANot Optionable
Transcat, Inc. stock logo
TRNS
Transcat
1,2459.32 million9.06 millionOptionable

Recent News About These Companies

Analysts Set Transcat, Inc. (NASDAQ:TRNS) PT at $112.20
Transcat: Another Deal, Another Earnings Lag
Transcat, Inc. (NASDAQ:TRNS) Short Interest Update
Invesco Ltd. Buys 3,270 Shares of Transcat, Inc. $TRNS
Transcat CEO Rudow to Retire
Transcat Announces CEO Succession Plan
Transcat, Inc. (TRNS) Q1 2026 Earnings Call Transcript
New Strong Buy Stocks for August 7th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.97 +0.32 (+8.77%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$3.96 -0.01 (-0.13%)
As of 08:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$1.34 +0.06 (+4.69%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$1.36 +0.01 (+1.12%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Prenetics Global stock logo

Prenetics Global NASDAQ:PRE

$14.27 -0.79 (-5.25%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$14.56 +0.30 (+2.07%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Transcat stock logo

Transcat NASDAQ:TRNS

$72.23 +1.69 (+2.40%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$72.21 -0.02 (-0.03%)
As of 10/3/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.